Barbara W. Bodem's most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 4,720 Common Stock done . Disclosure was reported to the exchange on May 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical In... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,720 | 6,900 (0%) | 0% | 0 | Common Stock | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 4,338 | 8,257 (0%) | 0% | 0 | Common stock, par value $0.001 | |
Option Care Health Inc. - ... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,325 | 7,056 (0%) | 0% | 0 | Common Stock | |
Option Care Health Inc. - ... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 1,731 | 1,731 (0%) | 0% | 0 | Common Stock | |
Biomarin Pharmaceutical In... | Barbara Bodem W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2023 | 2,180 | 2,180 (0%) | 0% | 0 | Common Stock | |
Syneos Health Inc - Ordina... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,863 | 8,385 (0%) | 0% | 0 | Class A Common Stock | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 4,167 | 4,167 | - | - | Director stock option (right to buy) | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 1,875 | 3,919 (0%) | 0% | 0 | Common stock, par value $0.001 | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 3,464 | 3,464 | - | - | Director Stock Option (right to buy) | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 1,648 | 2,044 (0%) | 0% | 0 | Common stock, par value $.001 | |
Enovis Corp | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 396 | 396 (0%) | 0% | 0 | Common stock, par value $.001 | |
Syneos Health Inc - Ordina... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,839 | 3,522 (0%) | 0% | 0 | Class A Common Stock | |
Syneos Health Inc - Ordina... | Barbara W. Bodem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 654 | 683 (0%) | 0% | 0 | Class A Common Stock |